Cardiopulmonary exercise testing screening and pre-operative pulmonary rehabilitation reduce postoperative complications and improve fast-track recovery after lung cancer surgery:...

por Gao, Ke, Yu, Peng-ming, Su, Jian-hua, He, Cheng-qi, Liu, Lun-xu, Zhou, Yu-bin, Pu, Qiang, Che, Guo-wei
Publicado 2015

ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma

por Zheng, Yu-Zhu, Ma, Rui, Zhou, Jian-Kang, Guo, Cheng-Lin, Wang, Yong-Sheng, Li, Zheng-Guang, Liu, Lun-Xu, Peng, Yong
Publicado 2016

Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after R0 resection: a propensity score-matched analysis

por Guo, Cheng-Lin, Mei, Jian-Dong, Jia, Yu-Long, Gan, Fan-Yi, Tang, Yu-Dong, Liu, Cheng-Wu, Zeng, Zhen, Yang, Zhen-Yu, Deng, Sen-Yi, Sun, Xing, Liu, Lun-Xu
Publicado 2021

Lymph node metastasis in Chinese patients with clinical T1 non‐small cell lung cancer: A multicenter real‐world observational study

por Chen, Bing, Wang, Xiaojun, Yu, Xinnian, Xia, Wen‐jie, Zhao, Heng, Li, Xiao‐fei, Liu, Lun‐xu, Liu, Yang, Hu, Jian, Fu, Xiang‐ning, Li, Yin, Xu, Yi‐jun, Liu, De‐ruo, Yang, Hai‐ying, Xu, Lin, Jiang, Feng
Publicado 2019

Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN Study

por Yang, Xue-Ning, Yan, Hong-Hong, Wang, Jun, Chu, Xiang-Yang, Liu, Zhi-Dong, Shen, Yi, Ma, Hai-Tao, Fu, Xiang-Ning, Hu, Jian, Zhou, Nai-Kang, Liu, Yong-Yu, Zhou, Xin-Ming, Li, Jing-Song, Yang, Kang, Li, Jian, Xu, Lin, Wang, Si-Yu, Wang, Qun, Liu, Lun-Xu, Xu, Shun, Chen, Zhong-Yuan, Lou, Hong-He, Wang, Chang-Li, Cheng, Ying, Liu, Si-Yang, Zhang, Xu-Chao, Zhong, Wen-Zhao, Wu, Yi-Long
Publicado 2021

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

por Zhong, Wen-Zhao, Wang, Qun, Mao, Wei-Min, Xu, Song-Tao, Wu, Lin, Wei, Yu-Cheng, Liu, Yong-Yu, Chen, Chun, Cheng, Ying, Yin, Rong, Yang, Fan, Ren, Sheng-Xiang, Li, Xiao-Fei, Li, Jian, Huang, Cheng, Liu, Zhi-Dong, Xu, Shun, Chen, Ke-Neng, Xu, Shi-Dong, Liu, Lun-Xu, Yu, Ping, Wang, Bu-Hai, Ma, Hai-Tao, Yang, Jin-Ji, Yan, Hong-Hong, Yang, Xue-Ning, Liu, Si-Yang, Zhou, Qing, Wu, Yi-Long
Publicado 2021

Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes

por Liu, Si-Yang, Bao, Hua, Wang, Qun, Mao, Wei-Min, Chen, Yedan, Tong, Xiaoling, Xu, Song-Tao, Wu, Lin, Wei, Yu-Cheng, Liu, Yong-Yu, Chen, Chun, Cheng, Ying, Yin, Rong, Yang, Fan, Ren, Sheng-Xiang, Li, Xiao-Fei, Li, Jian, Huang, Cheng, Liu, Zhi-Dong, Xu, Shun, Chen, Ke-Neng, Xu, Shi-Dong, Liu, Lun-Xu, Yu, Ping, Wang, Bu-Hai, Ma, Hai-Tao, Yan, Hong-Hong, Dong, Song, Zhang, Xu-Chao, Su, Jian, Yang, Jin-Ji, Yang, Xue-Ning, Zhou, Qing, Wu, Xue, Shao, Yang, Zhong, Wen-Zhao, Wu, Yi-Long
Publicado 2021

Clinical recommendations for perioperative immunotherapy‐induced adverse events in patients with non‐small cell lung cancer

por Ni, Jun, Huang, Miao, Zhang, Li, Wu, Nan, Bai, Chun‐Xue, Chen, Liang‐An, Liang, Jun, Liu, Qian, Wang, Jie, Wu, Yi‐Long, Zhang, Feng‐Chun, Zhang, Shu‐Yang, Chen, Chun, Chen, Jun, Fang, Wen‐Tao, Gao, Shu‐Geng, Hu, Jian, Jiang, Tao, Li, Shan‐Qing, Li, He‐Cheng, Liao, Yong‐De, Liu, Yang, Liu, De‐Ruo, Liu, Hong‐Xu, Liu, Jian‐Yang, Liu, Lun‐Xu, Wang, Meng‐Zhao, Wang, Chang‐Li, Yang, Fan, Yang, Yue, Zhang, Lan‐Jun, Zhi, Xiu‐Yi, Zhong, Wen‐Zhao, Guan, Yu‐Zhou, Guo, Xiao‐Xiao, He, Chun‐Xia, Li, Shao‐Lei, Li, Yue, Liang, Nai‐Xin, Lu, Fang‐Liang, Lv, Chao, Lv, Wei, Si, Xiao‐Yan, Tan, Feng‐Wei, Wang, Han‐Ping, Wang, Jiang‐Shan, Yan, Shi, Yang, Hua‐Xia, Zhu, Hui‐Juan, Zhuang, Jun‐Ling, Zhuo, Ming‐Lei
Publicado 2021